Your browser doesn't support javascript.
loading
Once-weekly semaglutide use in glucagon-like peptide-1 receptor agonist naïve patients with type 2 diabetes in North Macedonia: Real-world data from the MIRAGE study.
Milenkovikj, Tatjana; Chekorova Mitreva, Biljana; Jovanovska Mishevska, Sasha; Bitoska-Mileva, Iskra; Ahmeti, Irfan.
Afiliação
  • Milenkovikj T; University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Skopje, North Macedonia; Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, 1000 Skopje, Republic of North Macedonia. Electronic address: milenkovic.tatjana@yahoo.com.
  • Chekorova Mitreva B; Novo Nordisk Farma Dooel, Skopje, North Macedonia.
  • Jovanovska Mishevska S; University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Skopje, North Macedonia; Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, 1000 Skopje, Republic of North Macedonia.
  • Bitoska-Mileva I; University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Skopje, North Macedonia; Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, 1000 Skopje, Republic of North Macedonia.
  • Ahmeti I; University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Skopje, North Macedonia; Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, 1000 Skopje, Republic of North Macedonia.
Diabetes Res Clin Pract ; 206: 111018, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37972857

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Peptídeos Semelhantes ao Glucagon Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Peptídeos Semelhantes ao Glucagon Idioma: En Ano de publicação: 2023 Tipo de documento: Article